December 20, 2014 8:25 PM ET

Biotechnology

Company Overview of PharmaLundensis AB

Company Overview

PharmaLundensis AB operates as a pharmaceutical company in Sweden. It is conducting clinical research, which has completed Phase I and Phase IIa clinical stages for developing drug for the treatment of chronic obstructive pulmonary disease. The company was founded in 2006 and is based in Lund, Sweden.

Scheelevägen 2

Medicon Village

Lund,  223 81

Sweden

Founded in 2006

Phone:

46 46 13 27 80

Fax:

46 46 13 27 79

Key Executives for PharmaLundensis AB

PharmaLundensis AB does not have any Key Executives recorded.

PharmaLundensis AB Key Developments

PharmaLundensis AB to Report First Half, 2014 Results on Aug 14, 2014

PharmaLundensis AB announced that they will report first half, 2014 results on Aug 14, 2014

PharmaLundensis AB to Report Nine Months, 2014 Results on Nov 20, 2014

PharmaLundensis AB announced that they will report nine months, 2014 results on Nov 20, 2014

PharmaLundensis AB to Report Q1, 2014 Results on May 15, 2014

PharmaLundensis AB announced that they will report Q1, 2014 results on May 15, 2014

Similar Private Companies By Industry

Company Name Region
Toleranzia AB Europe
Premacure AB Europe
Oncorel AB Europe
Magnetic Biosolutions AB Europe
Percuseal Medical Systems Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PharmaLundensis AB, please visit www.pharmalundensis.se. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.